81 related articles for article (PubMed ID: 17074440)
1. Slow isomerization step in the interaction between mouse dopamine transporter and dopamine re-uptake inhibitor N-(3-iodoprop-2E-enyl)-2beta-carbo-[3H]methoxy-3beta-(4'-methylphenyl)nortropane.
Stepanov V; Järv J
Neurosci Lett; 2006 Dec; 410(3):218-21. PubMed ID: 17074440
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments.
Stepanov V; Schou M; Järv J; Halldin C
Appl Radiat Isot; 2007 Mar; 65(3):293-300. PubMed ID: 17081763
[TBL] [Abstract][Full Text] [Related]
3. N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.
Garreau L; Emond P; Belzung C; Guilloteau D; Frangin Y; Besnard JC; Chalon S
J Pharmacol Exp Ther; 1997 Jul; 282(1):467-74. PubMed ID: 9223589
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.
Page G; Chalon S; Emond P; Maloteaux JM; Hermans E
Neurochem Int; 2002 Feb; 40(2):105-13. PubMed ID: 11738476
[TBL] [Abstract][Full Text] [Related]
5. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909).
Stepanov V; Järv J
Neurochem Int; 2008 Dec; 53(6-8):370-3. PubMed ID: 18845198
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.
Chalon S; Garreau L; Emond P; Zimmer L; Vilar MP; Besnard JC; Guilloteau D
J Pharmacol Exp Ther; 1999 Nov; 291(2):648-54. PubMed ID: 10525084
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.
Schou M; Steiger C; Varrone A; Guilloteau D; Halldin C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4843-5. PubMed ID: 19577467
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter.
Emond P; Garreau L; Chalon S; Boazi M; Caillet M; Bricard J; Frangin Y; Mauclaire L; Besnard JC; Guilloteau D
J Med Chem; 1997 Apr; 40(9):1366-72. PubMed ID: 9135033
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.
Varrone A; Tóth M; Steiger C; Takano A; Guilloteau D; Ichise M; Gulyás B; Halldin C
J Nucl Med; 2011 Jan; 52(1):132-9. PubMed ID: 21189414
[TBL] [Abstract][Full Text] [Related]
10. [11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.
Saba W; Valette H; Schöllhorn-Peyronneau MA; Coulon C; Ottaviani M; Chalon S; Dolle F; Emond P; Halldin C; Helfenbein J; Madelmont JC; Deloye JB; Guilloteau D; Bottlaender M
Synapse; 2007 Jan; 61(1):17-23. PubMed ID: 17068778
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
12. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.
Zhen J; Chen N; Reith ME
Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
Chalon S; Hall H; Saba W; Garreau L; Dollé F; Halldin C; Emond P; Bottlaender M; Deloye JB; Helfenbein J; Madelmont JC; Bodard S; Mincheva Z; Besnard JC; Guilloteau D
J Pharmacol Exp Ther; 2006 Apr; 317(1):147-52. PubMed ID: 16339913
[TBL] [Abstract][Full Text] [Related]
14. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.
Ribeiro MJ; Ricard M; Lièvre MA; Bourgeois S; Emond P; Gervais P; Dollé F; Syrota A
Nucl Med Biol; 2007 May; 34(4):465-70. PubMed ID: 17499737
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
[TBL] [Abstract][Full Text] [Related]
16. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum.
Volz TJ; Bjorklund NL; Schenk JO
Synapse; 2005 Sep; 57(3):175-8. PubMed ID: 15945061
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).
Guilloteau D; Emond P; Baulieu JL; Garreau L; Frangin Y; Pourcelot L; Mauclaire L; Besnard JC; Chalon S
Nucl Med Biol; 1998 May; 25(4):331-7. PubMed ID: 9639293
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain.
Murthy V; Martin TJ; Kim S; Davies HM; Childers SR
J Pharmacol Exp Ther; 2008 Aug; 326(2):587-95. PubMed ID: 18492949
[TBL] [Abstract][Full Text] [Related]
20. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
